772 ACTIVE INTRAVENOUS DRUG USE DURING CHRONIC HEPATITIS C THERAPY DOES NOT REDUCE SUSTAINED VIROLOGIC RESPONSE RATES IN ADHERENT PATIENTS

2008 ◽  
Vol 48 ◽  
pp. S288
Author(s):  
P. Bruggmann ◽  
L.M. Falcato ◽  
B. Helbling ◽  
O. Keiser ◽  
S. Dober ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Drug Use ◽  
Chronic Hepatitis C ◽  
Sustained Virologic Response ◽  
Response Rates ◽  
Virologic Response ◽  
Intravenous Drug ◽  
Intravenous Drug Use ◽  
Hepatitis C Therapy

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients

2008 ◽  
Vol 15 (10) ◽  
pp. 747-752 ◽  
Author(s):  
P. Bruggmann ◽  
L. Falcato ◽  
S. Dober ◽  
B. Helbling ◽  
O. Keiser ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Drug Use ◽  
Sustained Virological Response ◽  
Chronic Hepatitis C ◽  
Virological Response ◽  
Response Rates ◽  
Intravenous Drug ◽  
Intravenous Drug Use ◽  
Hepatitis C Therapy

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C

2010 ◽  
Vol 30 (10) ◽  
pp. 1454-1460 ◽  
Author(s):  
Spilios Manolakopoulos ◽  
Melanie J. Deutsch ◽  
Olga Anagnostou ◽  
Stelios Karatapanis ◽  
Elli Tiniakou ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Drug Use ◽  
Chronic Hepatitis C ◽  
Drug Users ◽  
Antiviral Treatment ◽  
Intravenous Drug ◽  
Substitution Treatment ◽  
Intravenous Drug Use

Sustained virologic response rates (SVR-12) for chronic hepatitis C genotype 6 patients treated with Ledipasvir/Sofosbuvir or Sofosbuvir/Velpatasvir

2018 ◽  
Vol 68 ◽  
pp. S284-S285 ◽  
Author(s):  
E. Nguyen ◽  
S. Trinh ◽  
H. Trinh ◽  
H. Nguyen ◽  
K. Nguyen ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Sustained Virologic Response ◽  
Response Rates ◽  
Virologic Response

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin

2010 ◽  
Vol 52 (4) ◽  
pp. 501-507 ◽  
Author(s):  
Stefan Wirth ◽  
Carmen Ribes-Koninckx ◽  
Maria Angeles Calzado ◽  
Flavia Bortolotti ◽  
Lucia Zancan ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Sustained Virologic Response ◽  
Response Rates ◽  
Virologic Response ◽  
Peginterferon Alfa ◽  
High Sustained Virologic Response

scholarly journals Managing chronic hepatitis C acquired through intravenous drug use

QJM ◽  
2001 ◽  
Vol 94 (3) ◽  
pp. 153-158 ◽  
Author(s):  
S.L. Jowett
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Drug Use ◽  
Chronic Hepatitis C ◽  
Intravenous Drug ◽  
Intravenous Drug Use

Effects of Escitalopram Prophylaxis During Antiviral Treatment for Chronic Hepatitis C in Patients With a History of Intravenous Drug Use and Depression

2014 ◽  
Vol 75 (10) ◽  
pp. 1069-1077 ◽  
Author(s):  
Daphne M. Hotho ◽  
Geert Bezemer ◽  
Bettina E. Hansen ◽  
Arthur R. Van Gool ◽  
Robert J. de Knegt ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Drug Use ◽  
Chronic Hepatitis C ◽  
Antiviral Treatment ◽  
Intravenous Drug ◽  
Intravenous Drug Use ◽  
History Of

Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes

2006 ◽  
Vol 18 (2) ◽  
pp. 159-166 ◽  
Author(s):  
Geert Robaeys ◽  
Hans Van Vlierberghe ◽  
Catharina Mathe?? ◽  
Marc Van Ranst ◽  
Liesbeth Bruckers
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Drug Use ◽  
Chronic Hepatitis C ◽  
Intravenous Drug ◽  
Intravenous Drug Use ◽  
Effect Of Treatment

Lack of influence of active intravenous drug use on the management quality of patients with chronic hepatitis C

2003 ◽  
Vol 38 ◽  
pp. 134
Author(s):  
M. Cournot ◽  
F. Castel ◽  
F. Druart ◽  
T. Morin ◽  
V. Lauwers-Cances ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Drug Use ◽  
Chronic Hepatitis C ◽  
Intravenous Drug ◽  
Intravenous Drug Use ◽  
Management Quality

Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir

2018 ◽  
Vol 49 (1) ◽  
pp. 99-106 ◽  
Author(s):  
Emily Nguyen ◽  
Sam Trinh ◽  
Huy Trinh ◽  
Huy Nguyen ◽  
Khanh Nguyen ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Sustained Virologic Response ◽  
Response Rates ◽  
Virologic Response
Sign in / Sign up

Export Citation Format

Share Document